Abstract
Background Laboratory and physical metric data were available from participants of Alcohol Free for 40 (AFF40), a 40-day alcohol abstinence program in Louisiana. This study was performed to determine whether biometric changes were detectable after 40 days.
Materials and Methods This was a retrospective data review of three cohorts of AFF40 program participants. Participant pre- and post-program data were analyzed (n=113, 2019; n=105, 2020; n=344, 2021). The intervention was self-directed, 40-day alcohol abstinence with social support. Changes in liver enzymes, cholesterol, vitamin B12, weight, body fat, and blood pressure were measured. Paired t-tests were used to compare pre- and post-program metrics.
Results Retention rates for participation were 63% (113/179; 2019), 23% (105/449; 2020), and 86% (344/400; 2021), despite the SARS-CoV-2 pandemic in 2020 and 2021. Maximal average changes were - 9 mmHg in systolic blood pressure, -4.3 mmHg in diastolic blood pressure, and -5.7 pounds of weight (all p<0.0001). Liver enzymes decreased; alanine aminotransferase decreased by 5.6 U/L, aspartate transaminase by 4.8 U/L, and gamma glutamyl transferase by 8.7 U/L (all p<0.0001). Vitamin B12 increased by 54.6 pg/mL (p<0.01). Total cholesterol dropped by 15.8 mg/dL (p<0.0001).
Conclusion Participants in abstinence programming with social support improved liver enzymes, cholesterol, body fat, and other factors during a 40-day challenge.
Highlights
Programs for voluntary abstinence from alcohol have become popular around the world (Dry January, Sober October)
Alcohol Free for 40, a post-Mardi Gras abstinence program, revealed significant reductions in blood pressure, weight, fat, liver enzymes, total cholesterol, and increased vitamin B12 in participants after just 40 days
Program retention was high except in 2020 due to the SARS-CoV-2 pandemic
Dieticians and other healthcare practitioners can replicate Alcohol Free for 40 for individuals or groups who want to improve metrics described in this study
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was determined exempt by the Ochsner Clinic Foundation Institutional Review Board (FWA00002050).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author
